PDGFRA and gastrointestinal stromal tumor: Toward this path, Jones et al. reported a median PFS of 34 months (22.9—not reached) with avapritinib in pretreated patients with metastatic GIST bearing the specific PDGFRa D842V exon 18 mutation [10].